Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. handles a wide range of matters for life sciences clients, including public offerings, strategic patent advice and litigation. The practice’s leadership team is located in Boston and consists of Jonathan Kravetz and William Whelan, who handle a variety of financing structures and IPOs, and both are well-equipped to advise on venture capital investments, advising both investors and investees. Lewis Geffen leads on licensing transactions, supporting pharmaceutical, biotech and medical devices companies looking to fund drug research, while Thomas Wintner is the key contact for contentious matters, handling patent and trade secrets disputes concerning inter alia drugs, drug delivery systems and vaccines. Siegmund Gutman, who represents clients in patent disputes concerning biologics and in Hatch-Waxman disputes out of Los Angeles, joined the firm in May 2024 from Proskauer Rose LLP.